Jeffrey Deygoo, M.D.

NPI 1275920720ActiveIndividual· Pain Medicine, Interventional Pain Medicine· New York, NY

Pain Medicine, Interventional Pain Medicine (M.D.) in New York, New York, trained at New York Medical College (class of 2015). 280 Medicare patients in 2024, $271,745 paid; all of their 285 Part D prescriptions were generic. Abbott Laboratories was the largest of 2 companies reporting payments in 2025, $158.91 in all, mostly food and beverage.

Overview

NPI	1275920720
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	Yes
NPI issued	Apr 22, 2015
Last updated in NPPES	Aug 6, 2025
Certified by provider	Aug 6, 2025

Specialties and licenses

Taxonomy	Code	License	State
Pain Medicine, Interventional Pain Medicine Primary	208VP0014X	25MA10858500	NJ
Pain Medicine, Interventional Pain Medicine	208VP0014X	305111	NY

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pain Management (NJ); Practitioner - Pain Management (NY)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	280
Services billed	15,952 across 47 procedure codes
Paid by Medicare	$271,745

Part D prescriptions in 2024

Prescriptions (claims)	285 · 297 30-day fills
Patients	114
Total drug cost	$6,890
Generic share	100% of claims

Medicare sources and data years

Education and affiliations

Medical school	New York Medical College
Graduation year	2015
Medicare specialty	Pain Management
Secondary specialties	Anesthesiology
Telehealth	Offers telehealth